![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » GSK Presses for Removal of Controversial Judge
GSK Presses for Removal of Controversial Judge
May 23, 2005
GlaxoSmithKline (GSK), the British pharmaceutical concern, has submitted a complaint to the European Human Rights Tribunal in Strasbourg and the Constitutional Tribunal in Poland, connected with the import of medicines. The concern has appealed against the verdict of the Supreme Administrative Court (NSA) that refused to remove judge Ewa-Wrzesinska-Józków from ruling in GSK cases.
()a href="http://feeds.bignewsnetwork.com/redir.php?jid=e7682c066217daff&cat=6dcd932030878143" target="_blank">Big News Network
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct